Literature DB >> 20151969

Development of a scale to assess patient misperceptions about treatment choices for localized prostate cancer.

Hind A Beydoun1, Ravinder Mohan, May A Beydoun, John Davis, Raymond Lance, Paul Schellhammer.   

Abstract

OBJECTIVES: To develop a questionnaire to assess a patient's knowledge of his cancer, understanding of treatment choices, and judgement of his survival (KUJ) with and without treatment, as treatment for localized prostate cancer (LPC) can lead to urinary, sexual and bowel side-effects and might not improve survival in 75% of patients. PATIENTS AND METHODS: Although >90% of patients in the USA are diagnosed with LPC, approximately 94% of them choose treatment, such that newly diagnosed patients need individualized counselling to address misperceptions about the management of LPC. The internal consistency of an 18-item KUJ scale was evaluated among 184 patients recently diagnosed with LPC at a major urology practice. Principal-component analyses were applied for computing a KUJ index. Logistic regression modelling was used to identify predictors of the KUJ index.
RESULTS: Cronbach's alpha for the KUJ scale was 0.76. Nearly half of the patients provided incorrect answers to most KUJ items. Of the patients, 68% had an income of >US$50,000 and 90% had at least high (or secondary) school literacy level. Quality-of-life measures suggested that most patients were physically, mentally and socially healthy. Higher education, income and functional capacity were associated with worse KUJ.
CONCLUSION: The KUJ scale is internally consistent and clinicians can use it to identify the educational needs of patients with LPC before treatment selection. Overall, patients who were socioeconomically disadvantaged and those with physical ailments were better informed about the diagnosis, treatment options and prognosis of prostate cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20151969      PMCID: PMC2888927          DOI: 10.1111/j.1464-410X.2010.09209.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  28 in total

1.  Evidence-based patient choice: a prostate cancer decision aid in plain language.

Authors:  Margaret Holmes-Rovner; Sue Stableford; Angela Fagerlin; John T Wei; Rodney L Dunn; Janet Ohene-Frempong; Karen Kelly-Blake; David R Rovner
Journal:  BMC Med Inform Decis Mak       Date:  2005-06-20       Impact factor: 2.796

2.  Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote.

Authors:  Thomas D Denberg; Trisha V Melhado; John F Steiner
Journal:  Cancer       Date:  2006-08-01       Impact factor: 6.860

3.  Web-based electronic health information systems for prostate cancer patients.

Authors:  Howard H Pai; Francis Lau
Journal:  Can J Urol       Date:  2005-06       Impact factor: 1.344

Review 4.  Active surveillance for prostate cancer: for whom?

Authors:  Laurence Klotz
Journal:  J Clin Oncol       Date:  2005-11-10       Impact factor: 44.544

Review 5.  Treatment options for prostate cancer: evaluating the evidence.

Authors:  Vibha Bhatnagar; Robert M Kaplan
Journal:  Am Fam Physician       Date:  2005-05-15       Impact factor: 3.292

6.  Prostate cancer: demographic and behavioral correlates of stage at diagnosis among blacks and whites in North Carolina.

Authors:  E A Conlisk; E J Lengerich; W Demark-Wahnefried; J M Schildkraut; T E Aldrich
Journal:  Urology       Date:  1999-06       Impact factor: 2.649

7.  Prostate cancer knowledge among low income minority men.

Authors:  Christopher M Deibert; Sally Maliski; Lorna Kwan; Arlene Fink; Sarah E Connor; Mark S Litwin
Journal:  J Urol       Date:  2007-05       Impact factor: 7.450

8.  Do patients with localized prostate cancer treatment really want more aggressive treatment?

Authors:  Julia J van Tol-Geerdink; Peep F M Stalmeier; Emile N J T van Lin; Eric C Schimmel; Henk Huizenga; Wim A J van Daal; Jan-Willem Leer
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

9.  Incomplete and inconsistent information provided to men making decisions for treatment of early-stage prostate cancer.

Authors:  Stephanie L Snow; Rachel L Panton; Lorna J Butler; Derek R Wilke; Robert D H Rutledge; David G Bell; Ricardo A Rendon
Journal:  Urology       Date:  2007-05       Impact factor: 2.649

10.  Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening.

Authors:  W Demark-Wahnefried; T Strigo; K Catoe; M Conaway; M Brunetti; B K Rimer; C N Robertson
Journal:  Urology       Date:  1995-09       Impact factor: 2.649

View more
  4 in total

1.  Hospital racial composition and the treatment of localized prostate cancer.

Authors:  Craig Evan Pollack; Justin E Bekelman; K J Liao; Katrina Armstrong
Journal:  Cancer       Date:  2011-06-20       Impact factor: 6.860

2.  Physicians' perspectives on the informational needs of low-risk prostate cancer patients.

Authors:  Charlotte J Hagerman; Paula G Bellini; Kim M Davis; Richard M Hoffman; David S Aaronson; Daniel Y Leigh; Riley E Zinar; David Penson; Stephen Van Den Eeden; Kathryn L Taylor
Journal:  Health Educ Res       Date:  2017-04-01

3.  Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer.

Authors:  Jaclyn L F Bosco; Barbara Halpenny; Donna L Berry
Journal:  Health Qual Life Outcomes       Date:  2012-09-28       Impact factor: 3.186

4.  Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients.

Authors:  Jeffrey Belkora; June M Chan; Matthew R Cooperberg; John Neuhaus; Lauren Stupar; Tia Weinberg; Jeanette M Broering; Imelda Tenggara; Janet E Cowan; Stan Rosenfeld; Stacey A Kenfield; Erin L Van Blarigan; Jeffry P Simko; John Witte; Peter R Carroll
Journal:  Cancer Med       Date:  2019-11-12       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.